English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAvails Medical, Inc., a pioneer in accelerating antibiotic susceptibility testing (AST) solutions, is proud to announce the appointment of Mari Hoidal as Vice President of Marketing. With over 20 years of experience in healthcare and diagnostics marketing, Mari brings a wealth of expertise in developing and executing global marketing strategies.
Tag: Diagnostics
Feet First: AI Reveals How Infants Connect with Their World
Researchers explored how infants act purposefully by attaching a colorful mobile to their foot and tracking movements with a Vicon 3D motion capture system. The study tested AI’s ability to detect changes in infant movement patterns. Findings showed that AI techniques, especially the deep learning model 2D-CapsNet, effectively classified different stages of behavior. Notably, foot movements varied significantly. Looking at how AI classification accuracy changes for each baby gives researchers a new way to understand when and how they start to engage with the world.
NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics
A team of researchers from NUS Institute for Health Innovation & Technology (iHealthtech), led by Associate Professor Shao Huilin and Associate Professor Brian Lim, has developed a first-of-its-kind technology to map out diverse protein interactions in cells using DNA barcodes.
The technology, dubbed TETRIS, can explicitly identify and quantify multiple interacting partners in large protein assemblies. By capturing the complex hierarchy of protein interactions within tumour cells, the technology uncovers detailed molecular mechanisms driving disease progression. This enables more precise diagnostics, allowing for the accurate sub-typing of cancers and the identification of aggressive forms of the disease in just a few hours, which was not possible previously.
Bubbling, frothing and sloshing: Long-hypothesized plasma instabilities finally observed
PPPL scientists have observed new details of how plasma interacts with magnetic fields, potentially providing insight into the formation of enormous plasma jets that stretch between the stars.
UAlbany Chemist Available to Discuss Eli Lilly Alzheimer’s Drug
ALBANY, N.Y. (July 9, 2024) — Last week, the Food and Drug Administration (FDA) approved a new Alzheimer’s medication developed by Eli Lilly that has shown in clinical trials to moderately delay the progression of memory and cognitive decline in…
Bhatia named new head of ITER projects at PPPL
Ravinder Bhatia, a leader and engineer with three decades of experience managing collaborative science initiatives, is the new head of ITER projects at PPPL. In this role, Bhatia oversees the design and fabrication of six diagnostic systems that PPPL is building for ITER.
AACC Rebrands to the Association for Diagnostics & Laboratory Medicine
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a name change to the Association for Diagnostics & Laboratory Medicine.
How robots could help verify compliance with nuclear arms agreements
Ensuring that countries abide by future nuclear arms agreements will be a vital task. Now, PPPL researchers have helped devise an automated way to ensure compliance.
RNA Institute Researchers Advance DNA Nanostructure Stability
Researchers at the University at Albany’s RNA Institute have demonstrated a new approach to DNA nanostructure assembly that does not require magnesium. The method improves the biostability of the structures, making them more useful and reliable in a range of applications.
Early career scientist wins prestigious Hungarian physics award
Laszlo Horvath, an early career physicist at PPPL, is the winner of the 2022 Károly Simonyi Memorial Plaque from the Hungarian Nuclear Society.
Ask the expert: What are nanomedicines?
Morteza Mahmoudi, an assistant professor in MSU’s Department of Radiology, explains why addressing disagreements with stronger standards will help ensure future nanomedicines are safe, effective and successful.
Study Finds Genetic Method for Identifying Hundreds of Disease Agents ‘Promising’
In the pursuit of accurate diagnoses for illnesses, doctors have traditionally used multiple methods to try to identify the bacterium, virus, fungus or other pathogen responsible for an infection.
Study confirms the sensitivity of Techcyte’s AI solution for intestinal protozoa detection
A study authored by researchers at Quest Diagnostics and presented at ASM Microbe on June 9-12th 2022 in Washington, D.C. provides evidence that the Techcyte technology aids in the detection of intestinal protozoa.
Techcyte announces the release of their second generation AI for Human Parasites
Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, is proud to announce the release of their second-generation solution for Human Fecal Trichrome (HFT) for human parasites.
RBC Bioscience is Bringing its Lab Automation Solutions to the American Research and Diagnostics Market
Participation Announcement
New Research at the 2021 AACC Annual Scientific Meeting Captures SARS-CoV-2 Antibody Patterns in Vaccinated and Naturally Infected Individuals
Two new studies presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how antibodies against the SARS-CoV-2 virus can vary among recipients of different COVID-19 vaccines and naturally infected individuals. The findings provide critical data about the immune response to COVID-19 vaccines that could inform future diagnostic research and vaccination efforts.
Breaking Research That Could Advance COVID-19 Treatment and Testing Announced at the 2021 AACC Annual Scientific Meeting
A groundbreaking study shows that a new rapid test identifies COVID-19 patients who will deteriorate with greater accuracy than existing tests, thus helping patients to get life-saving treatment. Findings on this method, as well as a novel study on the performance of coronavirus tests in children, were presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.
SCIENION and Pictor Limited Partner to Commercialize High-Throughput SARS-CoV-2 Antibody Testing System to Support Ongoing Fight Against Pandemic
Today SCIENION, a BICO company, announced it has entered into a strategic collaboration with diagnostic biotechnology company Pictor Limited to commercialize a high throughput SARS-CoV-2 antibody testing system. In the collaboration, the two companies will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test to create the only platform capable of testing both anti-nucleocapsid and anti-spike antibodies in one reaction. This analysis will be key to support the sustained fight against the pandemic by measuring the population’s level of herd immunity through natural infections and vaccinations.
A New Test Could Improve Access to Mental Health Support for Healthcare Professionals Who Are Burned Out From the COVID-19 Pandemic
Research presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo shows that a new test could identify healthcare professionals who are experiencing high levels of work-related stress and anxiety. As COVID-19 cases surge again, this test could play a critical role in helping healthcare professionals on the frontlines of the pandemic to get essential mental health support.
New Noninvasive Tests for Colon and Prostate Cancer Presented at the 2021 AACC Annual Scientific Meeting
Two research teams have developed new noninvasive tests that use either blood or saliva samples to diagnose cases of colorectal cancer or prostate cancer, respectively. Presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, these tests could facilitate screening efforts for colorectal cancer and allow clinicians to better distinguish early-stage prostate cancer from more benign prostate conditions.
Novel Insights on COVID-19 Vaccines and Virus Evolution, Artificial Intelligence in the Clinic, Miniaturization of Diagnostic Platforms, and Much More to Be Explored at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo
At the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.
Clip Health (formerly Luminostics) Announces Company Rebranding, Immediate Product Pipeline
Clip Health has rebranded from Luminostics ahead of exciting product launches this fall.
Novel imaging agent identifies biomarker for iron-targeted cancer therapies
Reston, VA–A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted therapies for cancer patients. The radiotracer, 18F-TRX, can be used to measure iron concentration in tumors, which can help…
Early antiviral response in the nose may determine the course of COVID-19
Cells sampled at the time of diagnosis from patients who later developed severe COVID-19 show a muted antiviral response, study finds
MRI, clear cell likelihood score correlate with renal mass growth rate
Standardized non-invasive clear cell likelihood score–derived from MRI–correlates with the growth rate of small renal masses and may help guide personalized management
Artificial intelligence models to analyze cancer images take shortcuts that introduce bias
New study of artificial intelligence tools that analyze tumor images shows how they can make inaccurate predictions based on the institution that submitted the image
Thumb-sized device quickly ‘sniffs out’ bad breath
No one wants bad breath — not when visiting friends and family, at a job interview, and especially not on a first date. Smelly breath can make things awkward, but it also is a natural warning sign, indicating that serious…
Most studies of acute kidney injury are flawed due to non-use of standard definitions
In an article published in the American Journal of Kidney Diseases (AJKD), researchers found that among 176 studies on acute kidney injury, the Kidney Disease Improving Global Outcomes (KDIGO) definitions of kidney injury were inconsistently applied and 80% of studies…
Risk score with 6 routinely available lab tests accurately predicts kidney failure
Researchers developed a new risk equation, based on six routinely available patient parameters, that yielded improved performance in estimating the risk of a chronic kidney disease (CKD) patient to progress to end-stage kidney disease (ESKD) requiring kidney replacement therapy (KRT).…
From birth control to mammograms, many women missed out on preventive care for all of 2020
Study shows even after in-person care restarted, women were 20% to 30% less likely to get such services than in 2019, especially those from lower-income and higher-minority areas
Routine screening for BI-RADS lesions on automated whole-breast ultrasound
Return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast ultrasound substantially reduces the recall rate, while being unlikely to result in adverse outcome
Glaucoma test ‘best yet’
15-times more likely to detect high risk patients
Wearable sensors with wide-ranging strain sensitivity
Researchers draw inspiration from snake skin in sensor’s structural design
Limiting incident NA for efficient wavefront shaping through thin anisotropic scattering media
A team of researchers, affiliated with UNIST has succeeded in developing a new optical microscope technology, capable of deeper imaging beyond the biological tissues. This breakthrough has been led by Professor Jung-Hoon Park and his research team in the Department…
Short chain fatty acids: An ‘ace in the hole’ against SARS-CoV-2 infection
Scientists find that short chain fatty acids can be used to reduce susceptibility to SARS-CoV-2 infection and mortality from COVID-19
Keeping the world up to date on irritable bowel syndrome research in China
Scientists condense Chinese studies over the past decade on this common gastrointestinal disorder in a review article
Taming the Huntington’s disease proteome: Mass spectrometry may provide answers
Mass spectrometry has helped identify potential biomarkers and new treatment targets for Huntington’s disease report scientists in the Journal of Huntington’s Disease who reviewed 20 years of published studies
Novel screening approach improves diagnosis of metabolic disorders in newborns
A team led by researchers at Baylor College of Medicine found that a screening method known as untargeted metabolomics profiling can improve the diagnostic rate for inborn errors of metabolism, a group of rare genetic conditions, by about seven-fold when…
MRI can cut overdiagnoses in prostate-cancer screening by half
Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in The New England Journal of Medicine ,…
Reduced vs. standard CT dose for lung nodules in children, young adults with cancer
Reduced-dose CT depicts greater than 90% of lung nodules in children and young adults with cancer, identifying the presence of nodules with moderate sensitivity and high specificity
Newborn screening for epilepsy in sight through the discovery of novel disease biomarkers
The door has finally opened on screening newborn babies for pyridoxine-dependent epilepsy (PDE), a severe inherited metabolic disorder. This screening promises to enable better and earlier treatment of the disease. To identify new biomarkers that can be used in the…
Total-body PET imaging exceeds industry standards
Reston, VA–A performance evaluation of the uEXPLORER total-body PET/CT scanner showed that it exhibits ultra-high sensitivity that supports excellent spatial resolution and image quality. Given the long axial field of view (AFOV) of the uEXPLORER, study authors have proposed new,…
Study sheds light on mechanism of liposome accumulation in tumors
CU Cancer Center researcher says results could impact how we diagnose, monitor, and treat tumors with liposomes.
Artificial intelligence provides faster diagnosis for debilitating blistering disease
Scientists at the University of Groningen have trained an Artificial Intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita. The pattern is characteristic of a specific variant of the disease…
Understanding frailty will lead to better care for older adults
Frailty is a better predictor than factors such as age when determining how older adults fare one year after receiving critical care. A team led by researchers from the University of Waterloo analyzed data from more than 24,000 community-dwelling older…
The shape of nanoparticles in body fluids may help identify the type of cancer
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as “extracellular vesicles” (EVs), in body fluids could be a biomarker for identifying types of cancer. In the study, the scientists successfully measured…
Research paves the way to early diagnosis of diabetic neuropathy
Diabetics exert less force to hold an object than people with other diseases that affect the nervous system. Grip force is a key behavioral biomarker to detect incipient diabetic neuropathy
Molecular imaging improves staging and treatment of pancreatic ductal adenocarcinomas
Reston, VA–For patients with pancreatic ductal adenocarcinomas (PDAC), molecular imaging can improve staging and clinical management of the disease, according to research published in the June issue of The Journal of Nuclear Medicine . In a retrospective study of PDAC…
NIH Avant Garde Award for Out-Of-Box, Innovative Concept to Cure HIV and Treat Addiction
Multi-Disciplinary Approach to Eradicate All Traces of HIV from Body, and Treat Co-existing Substance Use Disorders/Addiction